Amrita V. Kamath
- Oncology top 5%
- HER2/EGFR in Cancer Research 16
- Drug Transport and Resistance Mechanisms 8
- CAR-T cell therapy research 5
-
- Monoclonal and Polyclonal Antibodies Research 24
- Hematology top 10%
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism 4
- Genetics top 10%
-
- Protein purification and stability 7
- Angiogenesis and VEGF in Cancer 6
-
- Antimicrobial Resistance in Staphylococcus 6
Amrita V. Kamath
57 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 103
- Oncology 641
- Radiology, Nuclear Medicine and Imaging 451
- Hematology 137
- Pharmacology 93
- Genetics 110
Countries citing papers authored by Amrita V. Kamath
This map shows the geographic impact of Amrita V. Kamath's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amrita V. Kamath with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amrita V. Kamath more than expected).
Fields of papers citing papers by Amrita V. Kamath
This network shows the impact of papers produced by Amrita V. Kamath. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amrita V. Kamath. The network helps show where Amrita V. Kamath may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Amrita V. Kamath, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 4 | |
| 3 | 2024 | 1 | |
| 4 | 2021 | 8 | |
| 5 | 2021 | 5 | |
| 6 | 2020 | 9 | |
| 7 | 2020 | 2 | |
| 8 | 2019 | 28 | |
| 9 | 2019 | 21 | |
| 10 | 2019 | 14 | |
| 11 | 2019 | 16 | |
| 12 | 2018 | 10 | |
| 13 | 2015 | 20 | |
| 14 | 2014 | 15 | |
| 15 | 2011 | 21 | |
| 16 | 2007 | 151 | |
| 17 | 2005 | 28 | |
| 18 | 2005 | 6 | |
| 19 | 2003 | 31 | |
| 20 | 1996 | 28 |
About Amrita V. Kamath
Amrita V. Kamath is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Immunology, having authored 58 papers that have together received 1.6k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (24 papers), HER2/EGFR in Cancer Research (16 papers), Drug Transport and Resistance Mechanisms (8 papers), Protein purification and stability (7 papers), Antimicrobial Resistance in Staphylococcus (6 papers), Angiogenesis and VEGF in Cancer (6 papers), CAR-T cell therapy research (5 papers) and Pharmacogenetics and Drug Metabolism (4 papers). The work is most often cited by research in Oncology (641 citations), Radiology, Nuclear Medicine and Imaging (451 citations) and Hematology (137 citations). Amrita V. Kamath has collaborated with scholars based in United States, France and Germany. Frequent co-authors include Suhasini Iyer, Punit H. Marathe, Francis Y. Lee, Marilyn E. Morris, Jian Wang, Yueping Zhang, Saeho Chong, R. M. Borzilleri, Ming Yao and Rong Deng. Their work appears in journals such as PLoS ONE, Clinical Cancer Research and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.